Detalhe da pesquisa
1.
Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial.
Lancet
; 384(9958): 1942-51, 2014 Nov 29.
Artigo
Inglês
| MEDLINE | ID: mdl-25103176
2.
INVESTIGATING THE EFFICACY OF CLINICAL TRIAL MONITORING STRATEGIES: Design and Implementation of the Cluster Randomized START Monitoring Substudy.
Ther Innov Regul Sci
; 49(2): 225-233, 2015 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-25973346
3.
Acceptance rate of clinical study endpoints and adequacy of source documentation: experience from clinical study endpoint review in NEAT001/ANRS143.
J Int AIDS Soc
; 17(4 Suppl 3): 19572, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-25394079